Leadership changes, September 2026
Executive appointments and departures from SEC 8-K filings, updated within hours of each filing.
Updated Nov 6, 2026
Changes
1,052
Appointments
619
Departures
64
Browse by role
September 2026
Get new CFO appointments the day the filing lands.
Filters
1,052 changes
| Filing date | Company | Person | Role | Change | Effective date | Source |
|---|---|---|---|---|---|---|
| Sep 8, 2026 | Clearway Energy, Inc. | Samantha Prout | Senior Vice President, Accounting and ControllerSenior Vice President, Accounting and Controller | Appointed | Sep 8, 2026 | SEC 8-K |
| Sep 8, 2026 | Concentra Group Holdings Parent, Inc. | Keith Newton | Executive Chairman of the Company’s Board of DirectorsExecutive Chairman of the Company’s Board of Directors | Role change | Nov 1, 2026 | SEC 8-K |
| Sep 8, 2026 | Concentra Group Holdings Parent, Inc. | Tanner Newton | Executive Vice President and Chief Financial OfficerCFO | Appointed | Nov 1, 2026 | SEC 8-K |
| Sep 8, 2026 | ENBRIDGE INC | Greg Ebel | President and Chief Executive OfficerCEO | Departed | Dec 31, 2026 | SEC 8-K |
| Sep 8, 2026 | ENBRIDGE INC | Michele Harradence | President and Chief Executive OfficerCEO | Appointed | Jan 1, 2027 | SEC 8-K |
| Sep 8, 2026 | FINANCIAL INSTITUTIONS INC | Bruce W. Harting | member of the Board of Directorsmember of the Board of Directors | Departed | Sep 1, 2026 | SEC 8-K |
| Sep 8, 2026 | FINANCIAL INSTITUTIONS INC | Susan R. Holliday | Director and Chair of the BoardDirector and Chair of the Board | Departed | Sep 3, 2026 | SEC 8-K |
| Sep 8, 2026 | Genpact LTD | Sumita Pandit | Senior Vice President and Chief Financial OfficerCFO | Appointed | Sep 9, 2026 | SEC 8-K |
| Sep 8, 2026 | Genpact LTD | Michael Weiner | Chief Financial OfficerCFO | Departed | Sep 8, 2026 | SEC 8-K |
| Sep 8, 2026 | Health Catalyst, Inc. | Benjamin Albert | Chief Executive Officer, President, principal executive officer and principal operating officer and member of the BoardCEO | Departed | Sep 13, 2026 | SEC 8-K |
| Sep 8, 2026 | Health Catalyst, Inc. | Benjamin Albert | Chief Business OfficerChief Business Officer | Appointed | Sep 14, 2026 | SEC 8-K |
| Sep 8, 2026 | HOULIHAN LOKEY, INC. | Gillian B. Zucker | directordirector | Appointed | n/a | SEC 8-K |
| Sep 8, 2026 | John Marshall Bancorp, Inc. | Christopher Bergstrom | President and Chief Executive OfficerCEO | Departed | n/a | SEC 8-K |
| Sep 8, 2026 | John Marshall Bancorp, Inc. | Christopher Bergstrom | Executive ChairmanExecutive Chairman | Appointed | n/a | SEC 8-K |
| Sep 8, 2026 | John Marshall Bancorp, Inc. | Brandon Lorey | Chief Executive OfficerCEO | Appointed | n/a | SEC 8-K |
| Sep 8, 2026 | John Marshall Bancorp, Inc. | Kent Carstater | President of JMSB and Chief Operating Officer of John Marshall BankPresident | Appointed | n/a | SEC 8-K |
| Sep 8, 2026 | John Marshall Bancorp, Inc. | Nicholas Smith | Chief Financial OfficerCFO | Appointed | n/a | SEC 8-K |
| Sep 8, 2026 | John Marshall Bancorp, Inc. | Joseph Zmitrovich | President of John Marshall Bank and Chief Revenue Officer of JMSBPresident | Appointed | n/a | SEC 8-K |
| Sep 8, 2026 | KIORA PHARMACEUTICALS INC | Keith Lane | Executive Vice President, Head of Clinical Development and Regulatory AffairsExecutive Vice President, Head of Clinical Development and Regulatory Affairs | Appointed | Sep 8, 2026 | SEC 8-K |
| Sep 8, 2026 | Kura Oncology, Inc. | Jennifer Fulk | Chief Financial OfficerCFO | Appointed | Sep 8, 2026 | SEC 8-K |
- Clearway Energy, Inc.Appointed
Samantha Prout Senior Vice President, Accounting and Controller
Filed Sep 8, 2026Effective Sep 8, 2026SEC 8-K
- Concentra Group Holdings Parent, Inc.Role change
Keith Newton Executive Chairman of the Company’s Board of Directors
Filed Sep 8, 2026Effective Nov 1, 2026SEC 8-K
Tanner Newton CFO
Filed Sep 8, 2026Effective Nov 1, 2026SEC 8-K
- ENBRIDGE INCDeparted
Greg Ebel CEO
Filed Sep 8, 2026Effective Dec 31, 2026SEC 8-K
- ENBRIDGE INCAppointed
Michele Harradence CEO
Filed Sep 8, 2026Effective Jan 1, 2027SEC 8-K
- FINANCIAL INSTITUTIONS INCDeparted
Bruce W. Harting member of the Board of Directors
Filed Sep 8, 2026Effective Sep 1, 2026SEC 8-K
- FINANCIAL INSTITUTIONS INCDeparted
Susan R. Holliday Director and Chair of the Board
Filed Sep 8, 2026Effective Sep 3, 2026SEC 8-K
- Genpact LTDAppointed
Sumita Pandit CFO
Filed Sep 8, 2026Effective Sep 9, 2026SEC 8-K
- Genpact LTDDeparted
Michael Weiner CFO
Filed Sep 8, 2026Effective Sep 8, 2026SEC 8-K
- Health Catalyst, Inc.Departed
Benjamin Albert CEO
Filed Sep 8, 2026Effective Sep 13, 2026SEC 8-K
- Health Catalyst, Inc.Appointed
Benjamin Albert Chief Business Officer
Filed Sep 8, 2026Effective Sep 14, 2026SEC 8-K
- HOULIHAN LOKEY, INC.Appointed
Gillian B. Zucker director
Filed Sep 8, 2026SEC 8-K
- John Marshall Bancorp, Inc.Departed
Christopher Bergstrom CEO
Filed Sep 8, 2026SEC 8-K
- John Marshall Bancorp, Inc.Appointed
Christopher Bergstrom Executive Chairman
Filed Sep 8, 2026SEC 8-K
- John Marshall Bancorp, Inc.Appointed
Brandon Lorey CEO
Filed Sep 8, 2026SEC 8-K
- John Marshall Bancorp, Inc.Appointed
Kent Carstater President
Filed Sep 8, 2026SEC 8-K
- John Marshall Bancorp, Inc.Appointed
Nicholas Smith CFO
Filed Sep 8, 2026SEC 8-K
- John Marshall Bancorp, Inc.Appointed
Joseph Zmitrovich President
Filed Sep 8, 2026SEC 8-K
- KIORA PHARMACEUTICALS INCAppointed
Keith Lane Executive Vice President, Head of Clinical Development and Regulatory Affairs
Filed Sep 8, 2026Effective Sep 8, 2026SEC 8-K
- Kura Oncology, Inc.Appointed
Jennifer Fulk CFO
Filed Sep 8, 2026Effective Sep 8, 2026SEC 8-K